Atlas Trials

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

Clinical trial NCT01046630 · COMPLETED

Trial details

NCT number
NCT01046630
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depression
Start date
2009-12-01
Primary completion
2011-03-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.